X-23000457-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_182699.4(DDX53):āc.400A>Gā(p.Ile134Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,210,189 control chromosomes in the GnomAD database, including 1 homozygotes. There are 107 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_182699.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX53 | NM_182699.4 | c.400A>G | p.Ile134Val | missense_variant | 1/1 | ENST00000327968.7 | NP_874358.2 | |
PTCHD1-AS | NR_073010.2 | n.343+63581T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDX53 | ENST00000327968.7 | c.400A>G | p.Ile134Val | missense_variant | 1/1 | 6 | NM_182699.4 | ENSP00000368667.2 | ||
ENSG00000289084 | ENST00000687119.1 | n.83-56309T>C | intron_variant | |||||||
ENSG00000289084 | ENST00000687248.1 | n.343+63581T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 31AN: 112025Hom.: 0 Cov.: 23 AF XY: 0.000263 AC XY: 9AN XY: 34189
GnomAD3 exomes AF: 0.000354 AC: 65AN: 183391Hom.: 1 AF XY: 0.000442 AC XY: 30AN XY: 67835
GnomAD4 exome AF: 0.000238 AC: 261AN: 1098108Hom.: 1 Cov.: 32 AF XY: 0.000270 AC XY: 98AN XY: 363468
GnomAD4 genome AF: 0.000277 AC: 31AN: 112081Hom.: 0 Cov.: 23 AF XY: 0.000263 AC XY: 9AN XY: 34255
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DDX53-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 19, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | DDX53: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at